• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：一种高灵敏度检测晚期肺腺癌患者血浆游离DNA中EGFR突变检测方法的临床验证。

Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.

出版信息

PLoS One. 2017 Dec 7;12(12):e0189549. doi: 10.1371/journal.pone.0189549. eCollection 2017.

DOI:10.1371/journal.pone.0189549
PMID:29216294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5720719/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0183331.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0183331。]

相似文献

1
Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.更正：一种高灵敏度检测晚期肺腺癌患者血浆游离DNA中EGFR突变检测方法的临床验证。
PLoS One. 2017 Dec 7;12(12):e0189549. doi: 10.1371/journal.pone.0189549. eCollection 2017.
2
Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.一种用于检测晚期肺腺癌患者血浆游离DNA中EGFR突变的高灵敏度检测方法的临床验证。
PLoS One. 2017 Aug 22;12(8):e0183331. doi: 10.1371/journal.pone.0183331. eCollection 2017.
3
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.前瞻性验证快速血浆基因分型检测晚期肺癌中 EGFR 和 KRAS 突变。
JAMA Oncol. 2016 Aug 1;2(8):1014-22. doi: 10.1001/jamaoncol.2016.0173.
4
Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.更正：ECT2高表达是非小细胞肺腺癌总生存期和无复发生存期较差的独立预后因素。
PLoS One. 2018 Apr 19;13(4):e0196354. doi: 10.1371/journal.pone.0196354. eCollection 2018.
5
Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors.
PLoS One. 2019 Mar 14;14(3):e0213984. doi: 10.1371/journal.pone.0213984. eCollection 2019.
6
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.用于检测晚期非小细胞肺癌患者血浆游离DNA中EGFR激活突变的高灵敏度液滴数字PCR方法
J Mol Diagn. 2015 May;17(3):265-72. doi: 10.1016/j.jmoldx.2015.01.004. Epub 2015 Mar 11.
7
Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.更正：美国表皮生长因子受体（EGFR）突变阳性非小细胞肺癌患者的真实世界管理
PLoS One. 2019 Feb 20;14(2):e0212831. doi: 10.1371/journal.pone.0212831. eCollection 2019.
8
Correction: Pockets as structural descriptors of EGFR kinase conformations.更正：作为表皮生长因子受体激酶构象结构描述符的口袋
PLoS One. 2018 Feb 8;13(2):e0192815. doi: 10.1371/journal.pone.0192815. eCollection 2018.
9
Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study.数字PCR检测晚期肺腺癌患者低水平表皮生长因子受体（EGFR）突变的评估：一项跨平台比较研究
Oncotarget. 2017 Jun 29;8(40):67810-67820. doi: 10.18632/oncotarget.18866. eCollection 2017 Sep 15.
10
Correction: quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.更正：配体-表皮生长因子受体相互作用的定量分析：一种筛选靶向分子的平台
PLoS One. 2015 Apr 13;10(4):e0124981. doi: 10.1371/journal.pone.0124981. eCollection 2015.

本文引用的文献

1
Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.一种用于检测晚期肺腺癌患者血浆游离DNA中EGFR突变的高灵敏度检测方法的临床验证。
PLoS One. 2017 Aug 22;12(8):e0183331. doi: 10.1371/journal.pone.0183331. eCollection 2017.